Delivery Order SPE2DB22D1017-SPE2DB25FG8WS
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order has a ceiling value of $2,598.96 and an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating it was awarded through open competition. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,512.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 14, 2025, with completion expected by July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis, psoriasis, and...
- The Defense Logistics Agency awarded a delivery order valued at $2,476.54 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of April 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,823.53 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. HUMIRA is a widely used...
- The Defense Logistics Agency awarded a delivery order valued at $5,700.00 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic medication for treating rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $32,943.62 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,883.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered from...
- The Defense Logistics Agency awarded a $3,043.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a biological immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract has no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,063.60 on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single-item pharmaceutical procurement with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...